Use of microgenomic technology for analysis of alterations in DNA copy number and gene expression in malignant melanoma

Clinical and Experimental Immunology, Supplement

Volumn 107, Issue SUPPL. 1, 1997, Pages 33-40

  Trent, J M ^c   Bittner, M ^d   Zhang, J ^d   Wiltshire, R ^d   Ray, M ^d   Su, Y ^d   Gracia, E ^d   Meltzer, P ^a   De Risi, J ^d   Penland, L ^b   Brown, P ^b  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d NONE

Author keywords

Gene expression; Genomics; Melanoma

Indexed keywords

COMPLEMENTARY DNA;

CHROMOSOME REARRANGEMENT; CONFERENCE PAPER; DNA STRUCTURE; GENE EXPRESSION; GENOME; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; MELANOMA; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CHROMOSOME MAPPING; DNA PRIMERS; DNA, NEOPLASM; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MELANOCYTES; MELANOMA; SKIN NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 0031032387     PISSN: 09642536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Kopf AW, Salopek TG, Slade J et al. Techniques of cutaneous examination for the detection of skin cancer. Cancer 1995; 75 (Suppl. 2):684-90.
2. Maestro R, Boiocchi, M. Sunlight and melanoma: an answer from MTS1 (p16) [letter; comment]. Science 1995; 267:5-16.
3. Donawho CK, Wolf P, Kripke ML. Enhanced development of murine melanoma in UV-irradiated skin: UV dose response, waveband dependence, and relation to inflammation. Melanoma Res 1994; 4:93-100.
4. Trent JM, Rosenfeld SB, Meyskens FL. Chromosome 6q involvement in human malignant melanoma. Cancer Genet. Cytogenet 1983; 9:177-80.
5. Becher R, Gibas Z, Karakousis C, Sandberg AA. Nonrandom chromosome changes in malignant melanoma. Cancer Res. 1983; 43:5010-16.
6. Balaban G, Herlyn M, Guerry D et al. Cytogenetics of human malignant melanoma and premalignant lesions. Cancer Genet Cytogenet 1984; 11:429-39.
7. Thompson FH, Emerson J, Olson S et al. Cytogenetics in 158 patients with regional or disseminated melanoma: Subset analysis of near diploid and simple karyotypes. Cancer Genet Cytogenet (in press).
8. Dracopoli NC, Harnett P, Bale SJ et al. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci 1989; 86:4614-18.
9. Millikin D, Meese E, Vogelstein B et al. Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. Cancer Res 1991; 51:5449-53.
10. Walker GJ, Palmer JM, Walter MK, Hayward NK. A genetic model of melanoma tumorigenesis based on allelic losses. Gene Chromosomes & Cancer 1995; 12:134-41.
11. Healy E, Rehman I, Angus B, Rees JL. Loss of heterozygosity in sporadic primary cutaneous melanoma. Gene Chromosomes & Cancer 1995; 12:152-6.
12. Trent JM, Stanbridge EJ, McBride HL et al. Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science 1990; 247:258-71.
13. Sandhu AK, Hubbard K, Kaur GP et al. Senescence of immortal human fibroblasts by the introduction of normal human chromosome 6. Proc Natl Acad Sci 1994; 91:5498-502.
14. Welch DR, Chen P, Miele ME et al. Microcell-mediated transfer of chromosome 6 into metastatic human C861 melanoma cells suppresses metastasis but does not inhibit tumorigenicity. Oncogene 1994; 9:255-62.
15. Kugo HM, Hashiba H, Shimizu M, Oshimura M. Suggestive evidence for functionally distinct, tumor-suppressor genes on chromosome 1 and 11 for a human fibrosarcoma cell line, HT1080. Oncogene 1990; 5:1637-44.
16. Tanaka K, Yanoshita R, Konishi M et al. Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 1p36 region. Oncogene 1993; 8:2253-8.
17. Negrini M, Sabbioni S, Possati L et al. Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: study on chromosome 6 and 11. Cancer Res1994; 54:1331-6.
18. Weaver-Feldhaus J, Gruis NA, Neuhausen S et al. Localization of a putative tumor suppressor gene by using homozygous deletions in melanoma. Proc Natl Acad Sci 1994; 91:7563-67.
19. Kamb A, Gruis NA, Weaver-Feldhau J et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994; 264:436-40.
20. Sager R. Tumor suppressor genes: the puzzle and the promise. Science 1989; 246:1406-12.
21. Meltzer PS, Guan XY, Trent JM. Telomere capture stabilizes chromosome breakage. Nat Genet 1993 4(3):252-5.
22. Zhang J, Trent JM, Meltzer PS. Rapid isolation and characterization of amplified DNA by chromosome microdissection: Identification of IGF1R amplification in malignant melanoma. Oncogene 1993; 8:2827-31.
23. Teleniu, H, Carter NP, Bebb CE et al. Degenerate oligonucleotide-primed PCR (DOP-PCR): General amplification of target DNA by a single degenerate primer. Genomics 1992; 13:718-25.
24. Zhang J, Meltzer PS, Jenkins R et al. Application of chromosome microdissection probes for elucidation of BCR-ABL fusion and variant Philadelphia chromosome translocations in chronic myelogenous leukemia. Blood 1993; 81:3365-71.
25. Meltzer PS, Guan XY, Burgess A, Trent JM. Rapid generation of region specific probes by chromosome microdissection and their application. Nat Genet 1992; 1(1):24-28.
26. Zhang J, Cui P, Glatfelter A et al. Microdissection based cloning of a translocation breakpoint in a human malignant melanoma. Cancer Res 1995; 55:4640-45.
27. Nisson PE, Rashtchian A, Watkins PC. Rapid and efficient cloning of Alu-PCR products using Uracil DNA glycosylase. PCR Meth and Appl 1991; 1:120-3.
28. Zhengping Z, Merino MJ, Chuaqui R et al. Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. Cancer Res 1995; 55:467-71.
29. Kallioniemi O-P, Kallioniemi A, Piper J et al. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chrom Cancer 1994; 10:231-43.
30. Pinkel D, Landegent J, Collins C et al. Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocation of chromosome 4. Proc Natl Acad Sci USA 1988; 85:9138-42.
31. Weaver-Feldhaus J, Gruis NA, Neuhausen S et al. Localization of a putative tumor suppressor gene by using homozygous deletions in melanoma. Proc Natl Acad Sci 1994; 91:7563-7.
32. Piper J, Rutovitz D, Sudar S et al. Computer image analysis of comparative genomic hybridization. Cytometry 1995; 19:10-26.
33. Gracia E, Fischer U, ElKahloun A et al. Isolation of genes amplified in human cancers by microdissection mediated cDNA capture. Hum Mol Genet (in press).
34. Trent JM, Thompson FH, Meyskens FL. Identification of a recurring translocation site involving chromosome 6 in human malignant melanoma. Cancer Res 1989; 49:420-3.
35. Ludwig C, Harper J, Payne C et al. Cellular and genetic properties of two melanoma cell lines established from the same tumor. Anticancer Res 1988; 8:9-16.
36. Hardas B, Ahang J, Trent J, Elder J. Direct evidence for homologous sequences on the paracentric regions of human chromosome 1. Genomics 1994; 21:359-63.
37. Elder DE, Murphy GF, eds. Atlas of Tumor Pathology: Melanocytic Tumors of the Skin. Washington DC:AFIP Press, 1990.
38. Herlyn M, Clark WH, Rodeck U et al. Biology of disease: biology of tumor progression in human melanocytes. Lab Invest 1987; 56:461-74.
39. Fountain JW, Bale SJ, Housman DE, Dracopli NC. Genetics of melanoma. Cancer Surveys 1990; 9:645-71.
40. Wiltshire R, Duray P, Bittner M et al. Direct visualization of the clonal progression of primary cutaneous melanoma: Application of tissue microdissection and comparative genomic hybridization. Cancer Res 1995; 55:3954-57.
41. Schena M, Shalon R, Davis R, Brown P. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270:467-70.
42. Ray M, Su Y, Meltzer P, Trent J. Isolation and characterization of genes associated with chromosome 6-mediated tumor suppression in human malignant melanoma. Oncogene (in press).